← Every applicant
Tandem Diabetes Care, Inc. FDA Approvals
0 new drug approvals and 12 device clearances on file. Matched by name to TNDM.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| Control-IQ+ technology510(k)Apr 24, 2026Clinical Chemistry |
| Tandem Mobi insulin pump with interoperable technology510(k)Nov 6, 2025Clinical Chemistry |
| t:slim X2 insulin pump with interoperable technology510(k)Sep 24, 2025Clinical Chemistry |
| Control-IQ+ technology510(k)May 21, 2025Clinical Chemistry |
| Control-IQ+ technology510(k)Feb 24, 2025Clinical Chemistry |
| Tandem Mobi Insulin Pump with interoperable technology510(k)Jul 26, 2024Clinical Chemistry |
| Tandem Mobi insulin pump with interoperable technology510(k)Mar 21, 2024Clinical Chemistry |
| Control-IQ Technology510(k)Nov 3, 2023Clinical Chemistry |
| t:slim X2 Insulin Pump with Interoperable Technology510(k)Nov 3, 2023Clinical Chemistry |
| Tandem Mobi insulin pump with interoperable technology510(k)Oct 5, 2023Clinical Chemistry |
| Tandem Mobi Insulin Pump with Interoperable Technology510(k)Jul 10, 2023Clinical Chemistry |
| t:slim X2 Insulin Pump with Interoperable Technology (with t:connect mobile app)510(k)Feb 15, 2022Clinical Chemistry |